{
    "clinical_study": {
        "@rank": "134529", 
        "brief_summary": {
            "textblock": "Although there is strong evidence that bisphosphonates prevent certain types of osteoporotic\n      fractures, there are concerns that these medications may be associated with rare atypical\n      femoral fractures (AFF). But the relationship between long-term bisphosphonate treatment and\n      AFF is unclear. In this study, the investigators would like to analyze the long term effects\n      on femur by bisphosphonate treatment.The participants are treated in the investigators\n      hospital more than four years."
        }, 
        "brief_title": "Radiographic Influences of Bisphosphonate Treatment on Femur", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Femur Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Femoral Fractures", 
                "Fractures, Bone"
            ]
        }, 
        "detailed_description": {
            "textblock": "Bisphosphonates have been widely used in the treatment of osteoporosis. Recently, long-term\n      use of bisphosphonates increases the risk for AFFs in older women, according to the results\n      of a population-based, nested case-control study. Unique radiographic pattern of AFF is\n      reported, such as simple transverse or short oblique fracture with breaking of medial cortex\n      and cortical thickness. But radiographic evaluation were performed for fracture patients in\n      previous reports and the femoral condition of long-term bisphosphonate treatment patients\n      before fracture is not known.\n\n      The main objective of this study is to reveal the effects of long-term bisphosphonate\n      treatment on femur."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients using bisphosphonate more than four years\n\n        Exclusion Criteria:\n\n          -  patients who could not use bisphosphonate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "45 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Oateoporosis patients using bisphosphonate more than four years."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01969279", 
            "org_study_id": "IRB TH No 6-2"
        }, 
        "intervention_browse": {
            "mesh_term": "Diphosphonates"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Osteoporosis", 
            "Bisphosphonate", 
            "Atypical femoral fracture", 
            "Side effect"
        ], 
        "lastchanged_date": "October 21, 2013", 
        "location": {
            "contact": {
                "email": "furikakefuri@hotmail.co.jp", 
                "last_name": "Rui Niimi, MD, PhD", 
                "phone": "(81)-59-365-0023"
            }, 
            "facility": {
                "address": {
                    "city": "Yokkaichi", 
                    "country": "Japan", 
                    "state": "Mie", 
                    "zip": "510-8008"
                }, 
                "name": "Tomidahama Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Radiographic Influences of Long-term Bisphosphonate Treatment on Femur", 
        "overall_contact": {
            "email": "furikakefuri@hotmail.co.jp", 
            "last_name": "Rui Niimi, MD, PhD", 
            "phone": "(81)-59-365-0023"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The investigators plan to analyze 120 patients who undergo bisphosphonate treatments more than four years.\nWe investigate radiographic features in patients with long-term bisphosphonate treatment. We investigate bilateral femur radiographs concerning to cortical thickening and cortical hypertrophy. We also investigate age and sex matched patients without bisphosphonate treatment as a control group.\nTo determine the bisphosphonate treatment effects on femur, statistical analyses are performed using Spearman correlation, paired t-test, chi-square test, Fisher's exact test and Mann-Whitney U test. Finally, we conclude the effects of bisphosphonate treatment on femur.", 
            "measure": "Influence of long-term bisphosphonate treatment on femur.", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 24 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01969279"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tomidahama Hospital", 
            "investigator_full_name": "Toshihiko Kono", 
            "investigator_title": "Head of Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The investigators plan to analyze 100 patients who undergo bisphosphonate treatments more than four months. To enroll 300 participants including drop-out patients, up to 60 months is required beside 48 months treatment periods.\nIn this study, we plan to evaluate longitudinal changes of femur. We evaluate femur radiographs at baseline and every one year. We investigate bilateral femur radiographs concerning to cortical thickening and cortical hypertrophy longitudinally. Statical analyses are performed using Spearman correlation coefficients, paired t-test, Mann-Whitney U test, chi-square test and Fisher's exact test.", 
            "measure": "Longitudinal effects of bisphosphonate treatments on femur", 
            "safety_issue": "Yes", 
            "time_frame": "Up to108 months"
        }, 
        "source": "Tomidahama Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tomidahama Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2000", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}